Issue

Vol. 29 No. 12 (2017): Vol 29 Issue 12

Copyright (c) 2017 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Sensitive and Validated Voltammetric Methods for Determination of Zileuton in Serum, Urine and Pharmaceutical Dosage Forms at Activated Glassy Carbon Electrode

https://doi.org/10.14233/ajchem.2017.20737
Nabil A. Alhemiary
Department of Chemistry, College of Science and Arts - Sharurah, Najran University, Sharurah, Saudi Arabia; Department of Chemistry, College Science, Ibb University, Ibb, Yemen
Moustfa A. Rizk
Department of Chemistry, College of Science and Arts - Sharurah, Najran University, Sharurah, Saudi Arabia; Department of Chemistry, College of Science, Suez Canal University, Ismailia, Egypt

Corresponding Author(s) : Nabil A. Alhemiary

alhemyri1000@yahoo.com

Asian Journal of Chemistry, Vol. 29 No. 12 (2017): Vol 29 Issue 12

Abstract

A simple, precise and sensitive voltammetric methods determination of zileuton were presented at activated glassy carbon electrode in Britton-Robinson buffer of pH 8 by differential pulse voltammetry and square wave voltammetry methods. A study of the variation of the peak current with solution variables such as pH, ionic strength, concentration of drug, possible interference and instrumental variables such as scan rate, pulse amplitude, accumulation potential, has resulted in the optimization of the reduction signal for analytical purposes. Linear calibration plots were obtained over the concentration ranges of 2.0 × 10-6 to 1.2 × 10-5 and 1.0 × 10-6 to 1.8 × 10-5 mol/L, respectively, using differential pulse voltammetry and square wave voltammetry methods. The correlation coefficients were 0.9977 and 0.9947 for differential pulse voltammetry and square wave voltammetry methods, respectively. The linear response was obtained in Britton-Robinson buffer in the range of 2.0 × 10-6 – 2.0 × 10-5 and 2.0 × 10-6 – 3.1 × 10-5 mol/L for spiked serum and urine samples, respectively. The limit of detection (LOD) and limit of quantification (LOQ) were 1.3 × 10-9 and 3.95 × 10-9 mol/L for differential pulse voltammetry method and 2.34 × 10-10 and 6.99 × 10-10 mol/L for square wave voltammetry method. The RSD for five measurements were 0.0489 and 0.0885 using 50 mV/s scan rate. The methods were applied for the determination of zileuton drug in dilute serum, urine samples and pharmaceutical dosage form with satisfactory results and compared with the official reference method. Complete validation of the proposed method was also done.

Keywords

Zileuton Differential pulse voltammetry Square wave voltammetry Cyclic voltammetry Activated glassy carbon electrode
Alhemiary, N. A., & Rizk, M. A. (2017). Sensitive and Validated Voltammetric Methods for Determination of Zileuton in Serum, Urine and Pharmaceutical Dosage Forms at Activated Glassy Carbon Electrode. Asian Journal of Chemistry, 29(12), 2627–2633. https://doi.org/10.14233/ajchem.2017.20737
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. R.B. Bell, P.R. Young, D. Albert, C. Lanni, J.B. Summers, D.W. Brooks, P. Rubin and G.W. Carter, Int. J. Immunopharmacol., 14, 505 (1992); https://doi.org/10.1016/0192-0561(92)90182-K.
  2. S.E. Wenzel and A.K. Kamada, Ann. Pharmacother., 30, 858 (1996).
  3. E. Israel, R. Dermarkarian, M. Rosenberg, R. Sperling, G. Taylor, P. Rubin and J.M. Drazen, N. Engl. J. Med., 323, 1740 (1990); https://doi.org/10.1056/NEJM199012203232505.
  4. E. Gounaris, M.J. Heiferman, J.R. Heiferman, M. Shrivastav, D. Vitello, N.R. Blatner, L.M. Knab, J.P. Phillips, E.C. Cheon, P.J. Grippo, K. Khazaie, H.G. Munshi and D.J. Bentrem, PLoS One, 6, 1 (2015); https://doi.org/10.1371/journal.pone.0121402.
  5. N. Morina, G. Bocari,A. Iljazi, K. Hyseini and G. Halac, Acta Inform. Med., 24, 16 (2016); https://doi.org/10.5455/aim.2016.24.16-19.
  6. W. Berger, M.T. De Chandt and C.B. Cairns, Int. J. Clin. Pract., 61, 663 (2007); https://doi.org/10.1111/j.1742-1241.2007.01320.x.
  7. P. Lu, M.L. Schrag, D.E. Slaughter, C.E. Raab, M. Shou and A.D. Rodrigues, Drug Metab. Dispos., 31, 1352 (2003); https://doi.org/10.1124/dmd.31.11.1352.
  8. Y. Qiu, H. Cheskin, J. Briskin and K. Engh, J. Control. Rel., 45, 249 (1997); https://doi.org/10.1016/S0168-3659(96)01574-X.
  9. C.C. Zouboulis, Dermatoendocrinol, 1, 188 (2009); https://doi.org/10.4161/derm.1.3.8368.
  10. K.K. Ananda and B.N. Naresh, Int. Res. J. Pharmacy, 3, 154 (2012).
  11. K.V. Prasada Rao, M. Tanuja, Y.S. Rao, T.H. Kumar, Int. J. Res. Pharm. Chem., 5, 251 (2015).
  12. G.R. Granneman, R.A. Braeckman and K.A. Erdman, Clin. Pharmacokinet., 29(Suppl. 2), 1 (1995); https://doi.org/10.2165/00003088-199500292-00003.
  13. J. Song, Y.B. Zhou, J.S. Ding, Central South Pharmacy, 343 (2005).
  14. P. Pian, E. Labovitz, K. Hoffman, C.F. Clavijo, R. Rzasa Lynn, J.L. Galinkin, A.A. Vinks, P. Malik and U. Christians, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 937, 79 (2013); https://doi.org/10.1016/j.jchromb.2013.08.014.
  15. S.B. Ganorkar and A.A. Shirkhedkar, Arab. J. Chem., 10, 360 (2017); https://doi.org/10.1016/j.arabjc.2013.05.013.
  16. V.K. Prasada Rao, M. Tanuja, Y. Srinivasa Rao and H.T. Kumar, Int. J. Drug Dev. Res., 7, 101 (2015).
  17. S.B. Ganorkar, A.A. Dhumal and A.A. Shirkhedkar, Arab. J. Chem., 10, 273 (2017); https://doi.org/10.1016/j.arabjc.2014.03.009.
  18. N.Y. Sreedhar, M.S. Nayak, K.S. Prasad, P.R. Prasad and C.N. Reddy, E-J. Chem., 7, 166 (2010); https://doi.org/10.1155/2010/251415.
  19. P. Katakam, K.A. Shanta and K. Rama Rao, Sci. Pharm., 82, 617 (2014); https://doi.org/10.3797/scipharm.1403-20.
  20. H.M. Elqudaby, G.M. Gehad and G.M.G. El Din, Int. J. Electrochem. Sci., 9, 856 (2014).
  21. M. Mazloum-Ardakani, H. Rajabi and H. Biotollahi, J. Argent. Chem. Soc., 97, 106 (2009).
  22. H.M. Elqudaby, G.G. Mohamed, F.A. Ali and S.M. Eid, Arab. J. Chem., 6, 327 (2013); https://doi.org/10.1016/j.arabjc.2011.05.019.
  23. B. Uslu, S.A. Özkan and Z. Sentürk, Anal. Chim. Acta, 555, 341 (2006); https://doi.org/10.1016/j.aca.2005.09.034.
  24. W. Xu, R. Lei, W. Cao, C. Guo, X. Zhang and S. Wang, J. Anal. Sci. Meth. Instr., 3, 75 (2013); https://doi.org/10.4236/jasmi.2013.32009.
  25. M.E. Swartz and I.S. Krull,Analytical Method Development and Validation, Marcel Dekker: New York, edn 1 (1997).
  26. J. Ermer and J.H. Miller, Method Validation in Pharmaceutical Analysis; A Guide to Best Practice, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pp. 301-336 (2005).
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 1 Download : 0